Nicotinamide N-oxide
Nicotinamide N-oxide is an endogenous metabolite of nicotinamide and a precursor in NAD+ biosynthesis, reduced back to nicotinamide by hepatic xanthine oxidase. This small molecule is used in research to study NAD+ metabolism, redox biology, and enzyme function in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1986-81-8
Product Name Alternative
1-oxynicotinamide, DrugMetabolite, Drug Metabolite, CXCR, CXC chemokine receptors, c-Myc, cMyc, Endogenous Metabolite, EndogenousMetabolite, Nicotinamide-N-oxide, Nicotinamide N oxide, Nicotinamide Noxide, Nicotinamide N-oxide, Nicotinamide, Nicotinamide 1-oxide, inhibit, Inhibitor
Field of Research
Cell Biology, Immunology & Inflammation, Metabolism Research, Pharmacology & Drug Discovery
Purity
99.61% (May vary between batches)
Solubility
DMSO:3.85 mg/mL (27.87 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (7.24 mM) ; H2O:Limited solubility
Smiles
NC (=O) C1=CC=C[N+] ([O-]) =C1
Molecular Formula
C6H6N2O2
Molecular Weight
138.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1286933-01 0.02 mg (E-Coli)
Recombinant Staphylococcus haemolyticus Glutamate--tRNA ligase (gltX)
Sign In for Pricing
View Details MBS1286933-02 0.02 mg (Yeast)
Recombinant Staphylococcus haemolyticus Glutamate--tRNA ligase (gltX)
Sign In for Pricing
View Details MBS1286933-03 0.1 mg (E-Coli)
Recombinant Staphylococcus haemolyticus Glutamate--tRNA ligase (gltX)
Sign In for Pricing
View Details MBS1286933-04 0.1 mg (Yeast)
Recombinant Staphylococcus haemolyticus Glutamate--tRNA ligase (gltX)
Sign In for Pricing
View Details MBS1286933-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus haemolyticus Glutamate--tRNA ligase (gltX)
Sign In for Pricing
View Details